1. American Academy of Child and Adolescent Psychiatry. (2011). AACAP practice parameter for the use of atypical antipsychotic medications in children and adolescents. Retrieved from http://www.aacap.org/galleries/PracticeParameters/Atypical_Antipsychotic_Medications_Web.pdf
2. American Academy of Pediatrics & American Academy of Child & Adolescent Psychiatry. (2009). Improving mental health services in primary care: Reducing administrative barriers to access and collaboration. Retrieved from http://practice.aap.org/content.aspx?aid=2275.pdf
3. Moderators, mediators, and other predictors of risperidone response in children with Autistic Disorder and irritability;Arnold;Journal of Child and Adolescent Psychopharmacology,2010
4. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children;Biederman;Biological Psychiatry,2005
5. Mental health need and access to mental health services by youths involved in child welfare: A national survey;Burns;Journal of the American Academy of Child and Adolescent Psychiatry,2004